Cysteine-Rich Whey Protein Isolate (CR-WPI) Ameliorates Erectile Dysfunction by Diminishing Oxidative Stress via DDAH/ADMA/NOS Pathway.

Nitric oxide synthase- (NOS-) dependent endothelial dysfunction induced by oxidative stress (OS) is assumed to play a pivotal role in the pathogenesis and progression of diabetes mellitus-related erectile dysfunction (DMED). Cysteine-rich whey protein isolate (CR-WPI) is a widely used protein supplement and has been confirmed to reduce reactive oxygen species (ROS) by increasing cellular antioxidant glutathione (GSH). However, it is currently unknown whether CR-WPI elicits therapeutic effects in DMED. Here, we provide diabetic rats with CR-WPI to determine its effect on DMED and the underlying mechanisms. The results suggest that CR-WPI supplementation increased GSH biosynthesis and reduced ROS content and simultaneously upregulated the dimethylarginine dimethylaminohydrolase (DDAH)/asymmetrical dimethylarginine (ADMA)/nitric oxide synthase (NOS) metabolic pathway. Evaluation of intracavernous pressure (ICP) also showed an improvement of penile erectile function in CR-WPI-treated rats. The results of the vitro cell culture showed that glutathione pretreatment protected corpus cavernosum smooth muscle cells (CCSMC) from H2O2-induced apoptosis by decreasing Caspase 9 and Caspase 3 expressions. These results augur well for the potential therapeutic application of dietary CR-WPI supplementation for treating diabetic erectile dysfunction.

High Concentration of Dezocine Induces Immune Escape of Lung Cancer and Promotes Glucose Metabolism through Up-Regulating PD-L1 and Activating the NF-κB Pathway.

BACKGROUND: Dezocine is an opioid analgesic that can affect the immune system. Here, we explored the synergy of high concentration of Dezocine and programmed death-ligand 1 (PD-L1) with regards to immune escape and glucose metabolism in lung cancer (LC). METHODS: PD-L1 level in human LC cell lines was determined and the influence of Dezocine at different concentrations for the proliferation of LC cells was identified. Next, LC cells were transfected to alter PD-L1 level, and exposed to Dezocine at 8 µg/mL to explore their effects on cell proliferation, production of interferon-γ (IFN-γ), contents of glucose, lactate, and NADPH/NADP+, and activation of the nuclear factor-κB (NF-κB) pathway. RESULTS: PD-L1 level was increased in LC cells and Dezocine (8 µg/mL) impaired the proliferation of LC cells. Down-regulating PD-L1 inhibited cell proliferation, enhanced production of IFN-γ, and reduced the contents of glucose, lactate, and NADPH/NADP+, while up-regulating PD-L1 caused the opposite results. Dezocine (8 µg/mL) induced immune escape and glucose metabolism in LC, and Dezocine-induced effects were reversed by down-regulating PD-L1. Dezocine (8 µg/mL) up-regulated PD-L1 by activating the NF-κB pathway. CONCLUSION: Dezocine at 8 µg/mL promotes immune escape and glucose metabolism in LC through up-regulating PD-L1 and activating the NF-κB pathway.

Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.

OBJECTIVE: To evaluate targeted magnetic resonance imaging/transrectal ultrasound (MRI/TRUS) fusion prostate biopsy versus systematic prostate biopsy and the two approaches combined for the detection of prostate cancer (PCa) and clinically significant PCa (csPCa) in our center. PATIENTS AND METHODS: From September 2018 to June 2020, a total of 161 patients with PI-RADS ≥3 were enrolled in this study. They were randomly to undergo either systematic prostate biopsy (systematic group) or targeted MRI/TRUS fusion prostate biopsy + systematic prostate biopsy (combined group). The clinical data and pathological results of biopsies were analyzed. RESULTS: The detection rate of PCa by targeted MRI/TRUS fusion prostate biopsy was higher than systematic prostate biopsy (38/81 vs. 33/81) in combinated group, but there was no significantly difference. The PCa detection rate in combinated group was significantly higher than systematic group (47/81 vs. 34/80, P = 0.049). There were 40 patients in combinated group and 22 patients in systematic group diagnosed as csPCa, respectively. The ratio of detected csPCa was much higher in combinated group (P = 0.032). In Gleason score no more than 6, the detected ratio of targeted MRI/TRUS fusion prostate biopsy was significantly lower than systematic biopsies in combinated group (P = 0.044). While, in Gleason score higher than 6, the detected ratios of targeted MRI/TRUS fusion prostate biopsy were all higher than systematic biopsies. CONCLUSIONS: Among patients with PI-RADS ≥ 3, targeted MRI/TRUS fusion prostate biopsy is superior to systematic prostate biopsy in the detection rate of PCa and csPCa, but it still misses some PCa patients, including csPCa. Combining targeted MRI/TRUS fusion prostate biopsy and systematic prostate biopsy can led to more detection of all PCas, especially csPCa.

Design of Blue Thermally Activated Delayed Fluorescent Emitter with Efficient Exciton Gathering Property for High-Performance Fully Solution-Processed Hybrid White OLEDs.

The blue thermally activated delay fluorescence (TADF) emitters are highly attractive in the fields of constructing hybrid white organic light-emitting diodes (WOLEDs) due to its high efficiency and color stability. However, few blue TADF emitters can withstand sequential orthogonal solvents, making it impossible to fabricate the fully solution-processed hybrid WOLEDs. Here, two TADF materials, PCz-4CzCN and TPA-4CzCN, were designed and synthesized by equipping the emissive core with nonconjugated bulky units, which can effectively enhance the solvent resistance ability without disturbing the TADF feature. The photophysical investigation indicates that phenylcarbazole unit can efficiently block the electromer formation to enhance the energy transfer and exciton utilization of the emitter. Accordingly, the blue OLEDs of PCz-4CzCN shows higher external quantum efficiency (EQE) of 22.6%, which is the best performance recorded among the fully solution-processed blue OLEDs. Upon further doping, the yellow phosphor PO-01, the fully solution-processed TADF-phosphor (T-P) hybrid WOLEDs was successfully obtained with high performance for the first time. Thanks to the efficient exciplex formation, the turn-on voltage of the white device is only 2.8 V, and the maximum brightness and power efficiency are as high as 53 300 cd m-2 and 38.5 lm W-1, respectively, which are even higher than the previous reported T-P hybrid WOLEDs with a vacuum-deposited electron transfer layer.

Exciplex Formation and Electromer Blocking for Highly Efficient Blue Thermally Activated Delayed Fluorescence OLEDs with All-Solution-Processed Organic Layers.

Highly efficient solution-processable emitters are greatly desired to develop low-cost organic light-emitting diodes (OLEDs). The recently developed thermally activated delayed fluorescence (TADF) materials are promising candidates, but blue TADF materials compatible with the all-solution-process have still not been achieved. Here, a series of TADF materials, named X-4CzCN, are developed by introducing the bulky units through an unconjugated linker, which realizes high molecular weight to enhance the solvent resistance ability without disturbing the blue TADF feature. Meanwhile, the peripheral wrapping groups efficiently inhibit the triplet-triplet and triplet-polaron quenching by isolating the energy-transfer and charge-transporting channels. The photophysical measurements indicate that a small variation in peripheral unit will have a noticeable effect on the luminescence efficiency. The enlarged volume of peripheral units will make the electroluminescent spectra blueshift, while enhancing the energy transfer of exciplex and blocking the energy leakage of electromer can facilitate the exciton utilization. As a result, the fully solution-processed blue OLED achieves a CIE of (0.16, 0.27), a low turn on voltage of 2.9 eV, and a high external quantum efficiency of 20.6 %. As far as we known, this is the first report of all-solution-processed TADF OLEDs with blue emission, which exhibits a high efficiency even comparable to the vacuum-deposited devices.

Design of efficient thermally activated delayed fluorescence blue host for high performance solution-processed hybrid white organic light emitting diodes.

Developing a solution-processible blue thermally activated delayed fluorescence (TADF) emitter for hybrid white organic light emitting diodes (WOLEDs) is still a challenge. In this work, two TADF blue emitters are designed and synthesized to explore a common strategy to qualify the small molecular TADF material as a solution-processible blue host. Systematic studies find that the molecular encapsulation by introducing unconjugated carbazoles as steric shields not only keeps the intrinsic TADF feature unchanged, but also effectively suppress the intermolecular interaction induced exciton quenching, which makes the material more efficient for solution-processing. The optimized solution-processed hybrid WOLEDs based on the encapsulated TADF blue host realized a highly efficient device performance with a maximum current efficiency (CE), power efficiency (PE) and external quantum efficiency (EQE) of 45.6 cd A-1, 40.9 lm W-1 and 17.0%, respectively, which are three times higher in device efficiency and twenty times higher in device lifetime than the corresponding device with an unencapsulated TADF blue host. Furthermore, the obtained device exhibits a high electroluminescence (EL) above 20 000 cd m-2 and a stable EL spectrum with nearly unchanged Commission International de L'Eclairage (CIE) coordinate at a wide range of applied voltages. These results clearly demonstrate that the molecular encapsulation of the TADF blue host is a superior and promising strategy to achieve high performance and color stable solution-processed hybrid WOLEDs.

Strategy for the Realization of Highly Efficient Solution-Processed All-Fluorescence White OLEDs-Encapsulated Thermally Activated Delayed Fluorescent Yellow Emitters.

Fabrication of highly efficient all thermally activated delayed fluorescence (TADF) white organic light-emitting diodes (WOLEDs) through solution-process still remains a big challenge. Here, two encapsulated TADF molecules with a small singlet-triplet energy gap (Δ EST) and high photoluminescence quantum yield (PLQY) were designed and synthesized as yellow emitters for solution-processed WOLEDs. The high current, power, and external quantum efficiencies of 41.6 cd A-1, 30.4 lm W-1, and 17.3% were achieved for the solution-processed all-fluorescence WOLEDs with a single-emission layer. In contrast, even with the same Δ EST and PLQY, the corresponding unencapsulated parent emitters will account for nearly 50% loss of the potential device efficiency. This is for the first time that the small molecular TADF blue host and TADF yellow guest are used to construct solution-processed all-fluorescence WOLEDs, which exhibit high efficiency comparable with most of the vacuum-deposited all-fluorescence white devices. These results not only demonstrate the great potential of TADF emitters in achieving highly efficient solution-processed WOLEDs, but also testify the key role of molecular encapsulation in reducing polar-exciton quenching and enhancing electroluminescence performance.

Design of encapsulated hosts and guests for highly efficient blue and green thermally activated delayed fluorescence OLEDs based on a solution-process.

The molecular aggregation and exciton-polaron interaction of the host-guest system were successfully restricted by efficient molecular encapsulation. The solution-processed blue and green TADF OLEDs have been realized with external quantum efficiencies above 23% by employing the encapsulated TADF host and guest as emission layers.

Highly Efficient All-Solution-Processed Fluorescent Organic Light-Emitting Diodes Based on a Novel Self-Host Thermally Activated Delayed Fluorescence Emitter.

Here, we conveniently designed and synthesized a self-host thermally activated delayed fluorescence (TADF) emitter, which can not only form a uniform thin film through wet-process, but also allow the subsequently deposition of electron transporting layer (ETL) by orthogonal solvent. By using this self-host material as emitter, the all-solution-processed multilayer TADF organic light emitting diodes (OLEDs) was successfully fabricated. The maximum current, power and external quantum efficiencies of this nondoped device are 46.3 cd A-1, 39.3 lm W1- and 15.5%, respectively, which are much higher than the values of all-solution-processed OLEDs based on tranditional fluorescence and even comparable to the TADF devices with vacuum-deposited ETL. Moreover, the device maintains the high efficiency of 42.9 cd A-1 and 39.0 cd A-1 at the luminance of 100 cd m-2 for display and 1000 cd m-2 for practical lighting. The high efficiency and small efficiency roll-off of the all-solution-processed fluorescent OLEDs can be attributed to the superiority of the newly designed self-host TADF emitter, which possesses the perfect electroluminescent property and sufficient solvent resistance at the same time.